1. Home
  2. ORC vs ABVX Comparison

ORC vs ABVX Comparison

Compare ORC & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORC
  • ABVX
  • Stock Information
  • Founded
  • ORC 2010
  • ABVX 2013
  • Country
  • ORC United States
  • ABVX France
  • Employees
  • ORC N/A
  • ABVX N/A
  • Industry
  • ORC Real Estate Investment Trusts
  • ABVX
  • Sector
  • ORC Real Estate
  • ABVX
  • Exchange
  • ORC Nasdaq
  • ABVX Nasdaq
  • Market Cap
  • ORC 623.6M
  • ABVX 722.3M
  • IPO Year
  • ORC 2013
  • ABVX N/A
  • Fundamental
  • Price
  • ORC $8.91
  • ABVX $8.08
  • Analyst Decision
  • ORC Buy
  • ABVX Strong Buy
  • Analyst Count
  • ORC 3
  • ABVX 7
  • Target Price
  • ORC $9.50
  • ABVX $37.86
  • AVG Volume (30 Days)
  • ORC 3.1M
  • ABVX 162.8K
  • Earning Date
  • ORC 01-30-2025
  • ABVX 03-24-2025
  • Dividend Yield
  • ORC 16.14%
  • ABVX N/A
  • EPS Growth
  • ORC N/A
  • ABVX N/A
  • EPS
  • ORC 0.58
  • ABVX N/A
  • Revenue
  • ORC $54,406,000.00
  • ABVX $9,676,417.00
  • Revenue This Year
  • ORC N/A
  • ABVX $31.67
  • Revenue Next Year
  • ORC N/A
  • ABVX $759.77
  • P/E Ratio
  • ORC $15.50
  • ABVX N/A
  • Revenue Growth
  • ORC N/A
  • ABVX 100.87
  • 52 Week Low
  • ORC $7.41
  • ABVX $5.50
  • 52 Week High
  • ORC $9.08
  • ABVX $17.02
  • Technical
  • Relative Strength Index (RSI)
  • ORC 79.15
  • ABVX 75.42
  • Support Level
  • ORC $8.25
  • ABVX $5.88
  • Resistance Level
  • ORC $8.35
  • ABVX $7.57
  • Average True Range (ATR)
  • ORC 0.15
  • ABVX 0.46
  • MACD
  • ORC 0.06
  • ABVX 0.24
  • Stochastic Oscillator
  • ORC 91.16
  • ABVX 97.68

About ORC Orchid Island Capital Inc.

Orchid Island Capital Inc invests in residential mortgage-backed securities (RMBS) across the United States. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

Share on Social Networks: